Valid for Submission
E34.3 is a billable diagnosis code used to specify a medical diagnosis of short stature due to endocrine disorder. The code E34.3 is valid during the fiscal year 2022 from October 01, 2021 through September 30, 2022 for the submission of HIPAA-covered transactions.
The ICD-10-CM code E34.3 might also be used to specify conditions or terms like acquired partial lipodystrophy, asexual dwarfism, asexual dwarfism, autosomal recessive asexual dwarfism, bone age finding , congenital stenosis of carotid artery, etc.
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code E34.3:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Constitutional short stature
- Laron-type short stature
Type 1 ExcludesType 1 Excludes
A type 1 excludes note is a pure excludes note. It means "NOT CODED HERE!" An Excludes1 note indicates that the code excluded should never be used at the same time as the code above the Excludes1 note. An Excludes1 is used when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- achondroplastic short stature Q77.4
- hypochondroplastic short stature Q77.4
- nutritional short stature E45
- pituitary short stature E23.0
- progeria E34.8
- renal short stature N25.0
- Russell-Silver syndrome Q87.19
- short-limbed stature with immunodeficiency D82.2
- short stature in specific dysmorphic syndromes - code to syndrome - see Alphabetical Index
- short stature NOS R62.52
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code E34.3 are found in the index:
- - Deficiency, deficient
- - Dwarfism - E34.3
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Acquired partial lipodystrophy
- Asexual dwarfism
- Asexual dwarfism
- Autosomal recessive asexual dwarfism
- Bone age finding
- Congenital stenosis of carotid artery
- Constitutional short stature
- Delayed bone age
- Disorder of tryptophan metabolism
- Dolichocephalic dwarfism
- Growth delay due to insulin-like growth factor I resistance
- Growth delay due to insulin-like growth factor type 1 deficiency
- Growth hormone receptor abnormality
- Growth hormone receptor absent
- Hereditary acantholytic dermatosis
- Hypothyroid dwarfism
- Infantile dwarf
- Internal carotid artery stenosis
- Keratosis follicularis, dwarfism, cerebral atrophy syndrome
- Laron syndrome with immunodeficiency
- Laron-type isolated somatotropin defect
- Lipodystrophy, partial, with Rieger anomaly, short stature, and insulinopenic diabetes mellitus
- Long narrow head
- Microcephalic osteodysplastic primordial dwarfism types I and III
- Microcephalic primordial dwarfism Alazami type
- Microcephalic primordial dwarfism Dauber type
- Microcephalic primordial dwarfism due to ZNF335 deficiency
- Microcephalic primordial dwarfism Montreal type
- Microcephalic primordial dwarfism Toriello type
- Microcephalus, hypergonadotropic hypogonadism, short stature syndrome
- Moyamoya angiopathy, short stature, facial dysmorphism, hypergonadotropic hypogonadism syndrome
- Moyamoya disease
- Osteodysplastic primordial dwarfism
- Primordial dwarfism
- Short stature co-occurrent and due to endocrine disorder
- Short stature due to growth hormone secretagogue receptor deficiency
- Short stature due to partial growth hormone receptor deficiency
- Short stature due to primary acid labile subunit deficiency
- Short stature with delayed bone age due to thyroid hormone metabolism deficiency
- Short stature, unique facies, enamel hypoplasia, progressive joint stiffness, high-pitched voice syndrome
- Short stature, wormian bones, dextrocardia syndrome
- Tryptophanuria with dwarfism
- X-linked asexual dwarfism
Diagnostic Related Groups - MS-DRG Mapping
|MS-DRG||MS-DRG Title||MCD||Relative Weight|
|643||ENDOCRINE DISORDERS WITH MCC||10||1.6633|
|644||ENDOCRINE DISORDERS WITH CC||10||1.0183|
|645||ENDOCRINE DISORDERS WITHOUT CC/MCC||10||0.7678|
The relative weight of a diagnostic related group determines the reimbursement rate based on the severity of a patient's illness and the associated cost of care during hospitalization.
Convert E34.3 to ICD-9 Code
Information for Patients
Does your child seem much shorter - or much taller - than other kids his or her age? It could be normal. Some children may be small for their age but still be developing normally. Some children are short or tall because their parents are.
But some children have growth disorders. Growth disorders are problems that prevent children from developing normal height, weight, sexual maturity or other features.
Very slow or very fast growth can sometimes signal a gland problem or disease.
The pituitary gland makes growth hormone, which stimulates the growth of bone and other tissues. Children who have too little of it may be very short. Treatment with growth hormone can stimulate growth.
People can also have too much growth hormone. Usually the cause is a pituitary gland tumor, which is not cancer. Too much growth hormone can cause gigantism in children, where their bones and their body grow too much. In adults, it can cause acromegaly, which makes the hands, feet and face larger than normal. Possible treatments include surgery to remove the tumor, medicines, and radiation therapy.
[Learn More in MedlinePlus]
Laron syndrome is a rare form of short stature that results from the body's inability to use growth hormone, a substance produced by the brain's pituitary gland that helps promote growth. Affected individuals are close to normal size at birth, but they experience slow growth from early childhood that results in very short stature. If the condition is not treated, adult males typically reach a maximum height of about 4.5 feet; adult females may be just over 4 feet tall.
Other features of untreated Laron syndrome include reduced muscle strength and endurance, low blood sugar levels (hypoglycemia) in infancy, small genitals and delayed puberty, hair that is thin and fragile, and dental abnormalities. Many affected individuals have a distinctive facial appearance, including a protruding forehead, a sunken bridge of the nose (saddle nose), and a blue tint to the whites of the eyes (blue sclerae). Affected individuals have short limbs compared to the size of their torso, as well as small hands and feet. Adults with this condition tend to develop obesity. However, the signs and symptoms of Laron syndrome vary, even among affected members of the same family.
Studies suggest that people with Laron syndrome have a significantly reduced risk of cancer and type 2 diabetes. Affected individuals appear to develop these common diseases much less frequently than their unaffected relatives, despite having obesity (a risk factor for both cancer and type 2 diabetes). However, people with Laron syndrome do not seem to have an increased lifespan compared with their unaffected relatives.
[Learn More in MedlinePlus]